HOME › DRUGS › CRIZANLIZUMAB-TMCA
ACTIVE SUBSTANCE / INN

CRIZANLIZUMAB-TMCA

Brand name(s): ADAKVEO
FDA LISTED
PRESCRIPTION
BLA761128
ACTIVE SUBSTANCE
Crizanlizumab-Tmca
REGULATORS
FDA
SPONSORS / MAH
NOVARTIS PHARMS CORP
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ADAKVEOBLA761128NOVARTIS PHARMS CORPPrescription

FULL INTELLIGENCE ON CRIZANLIZUMAB-TMCA

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →